--- title: "12 Health Care Stocks Moving In Friday's Intraday Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/287391477.md" description: "On Friday, Yojbaba (RYOJ) surged 178.8% to $5.61, while QTREX Quantum (QTEX) rose 173.95% to $0.83. Akari Therapeutics (AKTX) increased 120.03% to $11.31. Conversely, Aditxt (ADTX) plummeted 57.8% to $0.52, and NervGen Pharma (NGEN) fell 42.12% to $2.13. Other notable gainers included Geovax Labs (GOVX) and HCW Biologics (HCWB), while Liminatus Pharma (LIMN) and Black Diamond Therapeutics (BDTX) were among the biggest losers." datetime: "2026-05-22T17:05:54.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/287391477.md) - [en](https://longbridge.com/en/news/287391477.md) - [zh-HK](https://longbridge.com/zh-HK/news/287391477.md) generator: "portal-rs" --- # 12 Health Care Stocks Moving In Friday's Intraday Session ### Gainers - **rYojbaba** (NASDAQ:RYOJ) stock increased by 178.8% to $5.61 during Friday's regular session. The market value of their outstanding shares is at $22.6 million. - **QTREX Quantum** (NASDAQ:QTEX) shares increased by 173.95% to $0.83. - **Akari Therapeutics** (NASDAQ:AKTX) stock increased by 120.03% to $11.31. The company's market cap stands at $183.7 million. The company's, Q1 earnings came out 3 days ago. - **Geovax Labs** (NASDAQ:GOVX) shares rose 44.58% to $3.98. The market value of their outstanding shares is at $9.5 million. - **MetaVia** (NASDAQ:MTVA) stock increased by 33.1% to $3.82. The company's market cap stands at $14.8 million. - **HCW Biologics** (NASDAQ:HCWB) shares increased by 20.34% to $3.1. The market value of their outstanding shares is at $17.3 million. ### Losers - **Aditxt** (NASDAQ:ADTX) shares fell 57.8% to $0.52 during Friday's regular session. The company's market cap stands at $1.1 million. The company's, Q1 earnings came out 2 days ago. - **NervGen Pharma** (NASDAQ:NGEN) stock decreased by 42.12% to $2.13. The company's market cap stands at $297.8 million. - **Liminatus Pharma** (NASDAQ:LIMN) shares fell 37.65% to $0.15. The market value of their outstanding shares is at $11.0 million. - **Black Diamond Therapeutic** (NASDAQ:BDTX) shares declined by 26.34% to $2.62. The company's market cap stands at $203.4 million. - **WORK Medical Tech Gr** (NASDAQ:WOK) stock fell 21.51% to $0.13. - **Agape ATP** (NASDAQ:ATPC) stock declined by 20.06% to $2.87. The company's market cap stands at $3.5 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [AKTX.US](https://longbridge.com/en/quote/AKTX.US.md) - [NGEN.US](https://longbridge.com/en/quote/NGEN.US.md) - [ADTX.US](https://longbridge.com/en/quote/ADTX.US.md) - [BDTX.US](https://longbridge.com/en/quote/BDTX.US.md) - [RYOJ.US](https://longbridge.com/en/quote/RYOJ.US.md) - [QTEX.US](https://longbridge.com/en/quote/QTEX.US.md) - [GOVX.US](https://longbridge.com/en/quote/GOVX.US.md) - [MTVA.US](https://longbridge.com/en/quote/MTVA.US.md) - [HCWB.US](https://longbridge.com/en/quote/HCWB.US.md) - [LIMN.US](https://longbridge.com/en/quote/LIMN.US.md) - [WOK.US](https://longbridge.com/en/quote/WOK.US.md) - [ATPC.US](https://longbridge.com/en/quote/ATPC.US.md) - [GOVXW.US](https://longbridge.com/en/quote/GOVXW.US.md) - [LIMNW.US](https://longbridge.com/en/quote/LIMNW.US.md) ## Related News & Research - [Akari Therapeutics - Aktx-101 Demonstrates Robust Anti-Tumor Activity In Urothelial Cancer Preclinical Models](https://longbridge.com/en/news/296231720.md) - [Akari Targets Mid-2027 for Human Trial of Differentiated Cancer Therapy](https://longbridge.com/en/news/296250397.md) - [US families, healthcare providers under strain after Trump crackdown on Haitian immigrants](https://longbridge.com/en/news/296335867.md) - [Insider Selling: Tenable (NASDAQ:TENB) Director Sells $24,674.40 in Stock](https://longbridge.com/en/news/296616042.md) - [Nuveen NASDAQ 100 Dynamic Overwrite Fund (NASDAQ:QQQX) Stock Price Up 0.3% - Here's What Happened](https://longbridge.com/en/news/296667368.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**